Thymus Extract (generic name)

treats Burns, Urinary tract infection, Eczema, Cardiomyopathy, Dermatomyositis, Human papilloma virus, Psoriasis, Glaucoma, Alopecia, Arthritis...
Table of Contents
powered by healthline

Average Ratings

Evidence

DISCLAIMER: These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.

Allergy: Preliminary evidence suggests that thymus extract may be useful for allergy symptom reduction. More clinical trials are required before recommendations can be made involving thymus extract for this use.
Grade: C

Alopecia: Preliminary evidence suggests that thymus extract may be useful for hair re-growth. More clinical trials are required before recommendations can be made involving thymus extract for this use.
Grade: C

Anxiety/stress: Thymus extract has been investigated for use in immune-modulating acute stress and adaptive disorders. More clinical trials are required before recommendations can be made involving thymus extract for this use.
Grade: C

Arthritis: From the available evidence, any potential benefit of thymus extract is unclear. More clinical trials are required before recommendations can be made involving thymus extract for this use.
Grade: C

Asthma: Preliminary evidence suggests that thymus extract may be useful for asthma symptom reduction. More clinical trials are required before recommendations can be made involving thymus extract for this use.
Grade: C

Burns: Thymus extract may be useful for reducing infections, septicemia, and mortality. However, the evidence is mixed. More clinical trials are required before recommendations can be made involving thymus extract for this use.
Grade: C

Cancer: Preliminary evidence suggests that thymus extract may increase disease-free survival and immunological improvement. Early studies have investigated thymus extract for the treatment of hematopoietic cancer, histiocytosis X, larynx and oropharnygeal cancer, and skin cancer, among others. Additional study is needed in this area.
Grade: C

Cancer (chemotherapy adjunct): Preliminary evidence suggests that thymus extract may reduce side effects and infection rates associated with chemotherapy, and increase disease-free survival. Additional study is needed in this area.
Grade: C

Cancer (radiotherapy side effects): Preliminary evidence suggests intramuscular thymus extract may help treat immunodeficiency associated with radiotherapy. Additional study is needed in this area.
Grade: C

Cardiomyopathy: Preliminary evidence suggests that thymus extract may increase left ventricular function, exercise tolerance, and survival. Additional study is needed in this area.
Grade: C

Chronic obstructive pulmonary disease: Preliminary evidence suggests that thymus extract may be useful for reducing disease exacerbations and hospital admission. More clinical trials are required before recommendations can be made involving thymus extract for this use.
Grade: C

Dermatomyositis: Thymus extract is of interest for treatment of dermatomyositis (inflammation of the muscles) due to its role in immunostimulation. Additional study is needed in this area.
Grade: C

Diabetes: Preliminary evidence in conventionally treated patients with type I diabetes suggests that a combination of azathioprine and thymostimulin increased remission. Thymostimulin alone had no effect. Additional study is needed in this area.
Grade: C

Eczema: Preliminary evidence suggests that thymus extract has no clinical effect in patients with atopic eczema, despite anecdotal evidence suggesting the use of thymus extract for dermatological uses. Further well-designed clinical trials are still required before thymus extract can be recommended for this use.
Grade: C

Encephalitis: Preliminary evidence suggests that thymus extract has no clinical effect in patients with subacute sclerosing panencephalitis. However, additional study is needed in this area.
Grade: C

Gastritis: Preliminary evidence suggests that thymus extract speeds healing of gastric lesions. Further well-designed clinical trials are still required before thymus extract can be recommended for this use.
Grade: C

Glaucoma: Well-designed clinical trials are required before thymus extract can be recommended in the treatment of glaucoma.
Grade: C

HIV/AIDS: Preliminary evidence found no improvement in HIV progression to AIDS or immunostimulation, although some immunological activity was noted in a non-randomized controlled trial. Additional study is needed in this area.
Grade: C

Human papilloma virus (HPV): Thymus extract is of interest in the treatment of human papillomavirus due to its role in immunostimulation. Preliminary positive results were found in five cases. Additional study is needed in this area.
Grade: C

Immunostimulation: Preliminary evidence suggests that thymus extract increases T- and B-lymphocyte counts, the number of rosette-forming cells and response of T-lymphocytes. Also, in cancer patients, T-activin significantly increases the number of natural killer cells (CD16+). Additional study is needed in this area.
Grade: C

Keratitis: Preliminary evidence suggests that thymus extract, in addition to local treatment, reduces the recurrence rate of keratitis. Further well-designed clinical trials are still required before thymus extract can be recommended for this use.
Grade: C

Liver disease: Preliminary evidence suggests that thymus extract may offer benefit to individuals with HIV/AIDS and human papillomavirus. Also, thymus extract is of interest due to its role in immunostimulation. More well-designed clinical trials are required in the area of non-hepatitis B and hepatitis B liver disorders before recommendations can be made involving thymus extract for this use.
Grade: C

Myelodysplastic syndrome: Thymus extract is of interest in the treatment of myelodysplastic syndrome due to its role in immunostimulation in vitro and in human and animal studies. Additional study is needed in this area.
Grade: C

Psoriasis: Preliminary results suggest the combination of an intravenous thymus extract plus selenium and fumaric acid may increase healing rate. Additional study is needed in this area.
Grade: C

Respiratory tract infections: Preliminary evidence suggests that both intramuscular and oral thymus extract may be useful for reducing the presence of respiratory tract symptoms. Additional study is need in this area.
Grade: C

Skin conditions: Despite use of thymus extracts for dermatological conditions, there is currently inconclusive evidence recommending thymus extract for or against the use in skin conditions.
Grade: C

Systemic lupus erythematosus: Preliminary results indicate that articular and cutaneous symptoms associated with systemic lupus erythematosus can be improved with thymus extract use. Well designed clinical trials are required before thymus extract can be recommended for this use.
Grade: C

Tuberculosis: Although inconclusive, preliminary evidence suggests that thymus extract may improve effectiveness of antibacterial therapy in patients with tuberculosis. Well-designed clinical trials are required before recommendations can be made.
Grade: C

Urinary tract infection: Preliminary evidence from a controlled trial suggests that thymus extract reduces re-infection frequency and infection persistence. Further evidence is required before recommendations can be made.
Grade: C

Warts: Preliminary evidence suggests that thymus extract increased T cell count and activation in patients with warts. Further evidence is required before recommendations can be made.
Grade: C

Page: < Back 1 2 3 4 5 Next >
Licensed from
Top of page
General Drug Tools
General Drug Tools view all tools
Tools for
Healthy Living
Tools for Healthy Living view all tools
Search Tools
Search Tools view all tools
Insurance Plan Tools
Insurance Plan Tools view all tools

What is a reference number?

When you register on this site, you are assigned a reference number. This number contains your profile information and helps UnitedHealthcare identify you when you come back to the site.

If you searched for a plan on this site in a previous session, you might already have a reference number. This number will contain any information you saved about plans and prescription drugs. To use that reference number, click on the "Change or view saved information" link below.

You can retrieve information from previous visits to this site, such as saved drug lists and Plan Selector information.